Apellis Pharmaceuticals, Sobi Say EMA Validated Indication Extension Application for Potential Kidney Disease Treatment-December 2024-www.financetom.com

Apellis Pharmaceuticals, Sobi Say EMA Validated Indication Extension Application for Potential Kidney Disease Treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Apellis Pharmaceuticals, Sobi Say EMA Validated Indication Extension Application for Potential Kidney Disease Treatment

Feb 20, 2025 2:13 AM

04:45 AM EST, 02/20/2025 (MT Newswires) -- Apellis Pharmaceuticals ( APLS ) and Sobi said Thursday that the European Medicines Agency has validated an indication extension application for Aspaveli to treat C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis.

The submission was based on the results from a phase 3 trial that met its primary endpoint by reducing proteinuria in pegcetacoplan-treated patients by 68% as compared to placebo, the companies added.

C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis are two kinds of chronic kidney diseases without approved treatments.

Previous page： COLUMN-Aluminium flows shift after Trump doubles down on tariffs: Andy Home Next page： Adidas says tariffs will add $231 million to H2 costs

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

COLUMN-Aluminium flows shift after Trump doubles down on tariffs: Andy Home

Jul 29, 2025

LONDON, July 29 (Reuters) - Canadian aluminium smelters have started diverting primary metal away from the United States in response to the ratcheting up of import tariffs, first to 25% in March and then to 50% in June. Alcoa Corp ( AA ), which operates smelters on both sides of the border, has since March sold more than 100,000 metric...

Adidas says tariffs will add $231 million to H2 costs

Jul 29, 2025

July 30(Reuters) - Adidas on Wednesday said higher U.S. tariffs would add around 200 million euros ($231 million) to its costs in the second half, having impacted its second quarter results by double-digit millions of euros. The U.S. said earlier this month it would impose a 20% levy on many Vietnamese exports and a 19% tariff on goods from Indonesia,...

FOCUS-Trump's tariffs give chocolate makers in Canada, Mexico an edge over US firms

Jul 29, 2025

* Tariffs increase import costs for U.S. chocolate makers * Canada, Mexico can export chocolate to the U.S. tariff free * U.S.-based Taza Chocolate considered moving production to Canada * Data shows Canada chocolate exports to U.S. rose 10% this year By May Angel, Helen Reid and Jessica DiNapoli LONDON/NEW YORK, July 30 (Reuters) - U.S. President Donald Trump's trade...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...